National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation
Clinical trials sponsored by National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Massive blood pressure registry aims to personalize care Results expected Dec 2026 (estimated)
- Blood thinner safety under the microscope: 2,000 heart patients enrolled Results expected Dec 2026 (estimated)
- Massive registry aims to uncover hidden risks of blood thinners in heart patients Results expected Dec 2026 (estimated)
- New pill aims to keep heart in rhythm after AFib episode Results expected Dec 2026 (estimated)
- Heart failure clues: study tracks 500 patients for 3 years Results expected Dec 2026 (estimated)
-
New pill aims to keep heart in rhythm after AFib episode
Disease control OngoingThis study tests whether a new drug called Refralon, taken as a tablet once or twice daily, can prevent atrial fibrillation or flutter from returning after normal heart rhythm has been restored. About 175 adults with persistent AFib will receive either Refralon or a placebo for 6…
Phase 2 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug oxacom® shows promise for treating rare lung condition
Disease control OngoingThis study tests a new drug, Oxacom®, in 200 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The drug is given in different doses to see if it can lower pressure in the lung's blood vessels better than a placebo. The goal…
Phase 2/3 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC